Tirzepatide

32 API suppliersProtein

Overview

Tirzepatide is a protein active pharmaceutical ingredient (ChEMBL CHEMBL4297839).

API suppliers (32)

Suppliers of Tirzepatide evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

Where these suppliers are
China20India3United States1Netherlands1

Country recorded for 25 of 32 suppliers.

5 of 32 hold a GMP certificate on record in the EU or UK registers

Showing 25 of 32 suppliers — see the full list in the app.

Patent & exclusivity (US)

Per the FDA Orange Book (48 approved US products), the latest listed US patent on Tirzepatide expires 30 Dec 2041 and exclusivity 19 Dec 2028. Generic API sourcing typically opens up once these lapse.

Verified Supplier Partner

Do you supply Tirzepatide? Get in front of buyers actively sourcing it.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.